Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2011-08-30
2011-08-30
Westerberg, Nissa (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S400000, C424S457000, C424S489000
Reexamination Certificate
active
08007827
ABSTRACT:
The present invention relates generally to pharmaceutical dosage forms comprising: an absorption window active agent; a controlled release component comprising enteric-coated controlled release beads, wherein the enteric-coated release beads comprise at least two pH-sensitive polymer layers. The controlled-release dosage forms provide good bioavailability of absorption window active agents.
REFERENCES:
patent: 3080294 (1963-03-01), Shepard
patent: 4497826 (1985-02-01), Narabayashi et al.
patent: 4764380 (1988-08-01), Urquhart et al.
patent: 4780463 (1988-10-01), Sunshine et al.
patent: 4968508 (1990-11-01), Oren et al.
patent: 4996058 (1991-02-01), Sinnreich
patent: 5091184 (1992-02-01), Khanna
patent: 5133974 (1992-07-01), Paradissis et al.
patent: 5202128 (1993-04-01), Morella et al.
patent: 5217720 (1993-06-01), Sekigawa et al.
patent: 5229131 (1993-07-01), Amidon et al.
patent: 5651985 (1997-07-01), Penners et al.
patent: 5719185 (1998-02-01), Bountra et al.
patent: 5840329 (1998-11-01), Bai
patent: 6068859 (2000-05-01), Curatolo et al.
patent: 6110494 (2000-08-01), Clancy et al.
patent: 6156343 (2000-12-01), Morita et al.
patent: 6228398 (2001-05-01), Devane et al.
patent: 6248363 (2001-06-01), Patel et al.
patent: 6294200 (2001-09-01), Conte et al.
patent: 6350769 (2002-02-01), Kaufman et al.
patent: 6455527 (2002-09-01), Tulshian et al.
patent: 6544998 (2003-04-01), Mylari
patent: 6627223 (2003-09-01), Percel et al.
patent: 6645524 (2003-11-01), Midha et al.
patent: 6664069 (2003-12-01), Andrews et al.
patent: 6669957 (2003-12-01), Laruelle et al.
patent: 6692769 (2004-02-01), Ishibashi et al.
patent: 2002/0091250 (2002-07-01), Kaupmann et al.
patent: 2003/0021845 (2003-01-01), Friedman et al.
patent: 2003/0104062 (2003-06-01), Berner et al.
patent: 2003/0142035 (2003-07-01), Goldstein
patent: 2003/0228360 (2003-12-01), Han et al.
patent: 2006/0210631 (2006-09-01), Patel et al.
patent: 2006/0246134 (2006-11-01), Venkatesh
patent: 2007/0265343 (2007-11-01), Dharmadhikari et al.
patent: 2007/0292510 (2007-12-01), Huang
patent: WO 03/101432 (2003-12-01), None
Aisen et al., 15(4) Journal of the American Paraplegia Society 211-216 (1992).
Balerio et al., 27(7) Gen. Pharmac. 1269-1271 (1996).
Balerio et al., 27(3) European Journal of Drug Metabolism and Pharmacokinetics 163-169 (2002).
Cercos-Fortea et al., 16 Biopharmaceutics & Drug Disposition 563-577 (1995).
Merino et al., 10 Biopharmaceutics & Drug Disposition 279-297 (1989).
Moll-Navarro et al., 85(11) Journal of Pharmaceutical Sciences 1248-1254 (1996).
Nacher et al., 15 Biopharmaceutics & Drug Disposition 373-382 (1994).
Schapiro. Current Neurology and Neuroscience Reports 299-302 (2001).
Wuis et al., 12(2) Pharmaceutisch Weekblad Scientific Edition 71-74 (1990).
“Data Sheet: APO Baclofen” http://www.medsafe.govt.nz/profs/datasheet/a/apobaclofentab.htm Jun. 1999.
Han Chien-Hsuan
Hsu Ann F.
Hsu Larry
Adriano & Associates
Impax Laboratories, Inc.
Westerberg Nissa
LandOfFree
Pharmaceutical dosage forms having immediate release and/or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical dosage forms having immediate release and/or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical dosage forms having immediate release and/or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2753026